AAV gene therapy

Tuberous sclerosis (TSC) 1/2

estimated prevalence

100,000

Disease

Tuberous sclerosis (TSC) 1/2

Genetic Source

TSC

Clinical Phase

Pre-clinical

Modality

gene therapy

our science

our science icon icon

our approach icon icon

patient resources icon icon